2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP) (Middle Region) Peptide
Quick Overview for 2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP) (Middle Region) Peptide (ABIN8093602)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- CNP Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-CNP antibody ( ARP33879_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Cnpase (CNP) (2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP))
-
Background
-
Background Information: CNP belongs to the cyclic nucleotide phosphodiesterase family. It interacts with tubulin and promotes microtubule assembly for process outgrowth in oligodendrocytes. reduced CNP expression in the schizophrenic brain is relevant to disease etiology and therefore provide support for the general hypothesis that altered oligodendrocyte function is an etiological factor in schizophrenia.
Alternative Symbols: CNP1
-
Molecular Weight
- 47kDa
-
Gene ID
- 1267
-
NCBI Accession
- NP_149124
-
UniProt
- P09543
Target
-